The Valens Company Inc.
NASDAQ: VLNS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jeffrey Fallows CFA
- Employees
- 445
- Headquarters
- Toronto, Canada
- IPO year
- 2009
- Market cap
- $61.5M
- Website
- https://www.thevalenscompany.com
Loading VLNS…
Loading profile data…Frequently asked questions about VLNS
What does The Valens Company Inc. (VLNS) do?
The Valens Company Inc. is a Canadian-headquartered enterprise with international reach, focused on the development, manufacturing, and sale of cannabinoid-based products. Its product portfolio encompasses dried cannabis and hemp biomass, alongside a wide array of consumer goods such as tinctures, two-piece caps, soft gels, oral sprays, vape pen...
Where does VLNS trade?
The Valens Company Inc. (VLNS) trades on the NASDAQ Capital Market.
What sector is VLNS in?
The Valens Company Inc. (VLNS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of The Valens Company Inc.?
Jeffrey Fallows CFA is the chief executive officer of The Valens Company Inc. (VLNS).
Where is The Valens Company Inc. headquartered?
The Valens Company Inc. is headquartered in Canada.
Does VLNS pay a dividend?
The Valens Company Inc. (VLNS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VLNS go public?
The Valens Company Inc. (VLNS) completed its initial public offering in 2009.
Is VLNS an ADR?
Yes — VLNS is an American Depositary Receipt; its underlying shares trade on a non-US exchange. The Valens Company Inc. reporting and dividends follow the underlying issuer.